Blood-based biomarkers for neurodegenerative diseases are essential for implementing large-scale clinical studies. A reliable and validated blood test should require a small sample volume as well as be a less invasive sampling method, affordable, and reproducible. This paper demonstrates that high-throughput capillary electrophoresis immunoassay satisfies criteria for potential biomarker development.
Sage, J. M., Hall, L., McVey, A., Barohn, R. J., Statland, J. M., Jawdat, O., Dimachkie, M. M., Agbas, A. Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets. J. Vis. Exp. (156), e60638, doi:10.3791/60638 (2020).